Drug delivery researchers at Oregon State University have created a device that could enhance gene therapy for patients with inherited lung diseases like cystic fibrosis, according to a study led by Professor Gaurav Sahay and published in ACS Nano.
In a recent study published in Proceedings of the National Academy of Sciences, scientists at the University of Miami Miller School of Medicine's Sylvester Comprehensive Cancer Center developed a nanoparticle that can deliver drugs to both breast tumors and brain metastases by crossing the blood-brain barrier.
An international group of bioengineers and chemists from Rice University and the University of Houston have made great progress toward developing a biomaterial that may be utilized to cultivate biological tissues outside the human body.
Researchers from Tokyo University of Science (TUS) have developed nanoparticles from rice bran which demonstrated potent anticancer effects in mice models.
Recent studies published in Nature Communications by an international team of scientists from Michigan State University showed that nanoparticles can traverse the digestive system and deliver medication directly to brain tissue.
With a $2.07 million, four-year grant from the National Institutes of Health, Jianjun Guan, a materials scientist at Washington University in St. Louis’ McKelvey School of Engineering, and his team intend to encase a peptide that prevents fibrosis and a set of proteins that reduce inflammation inside deceptively disguised drug-delivering smart nanoparticles.
Researchers have created protein-only micromaterials that can deliver nanoparticles that target and kill particular cancer cells over an extended period of time.
Purdue University researchers are creating and testing patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to improve immunotherapy against malignant tumors.
Israeli and Italian researchers have worked together to create a novel treatment plan that targets A-beta’s early-stage aggregation prior to the production of harmful oligomers.
According to a recent review published by Prof. Changyang Gong’s research team at Sichuan University’s Department of Biotherapy, Cancer Center, and State Key Laboratory of Biotherapy, West China Hospital, the rapid development of nanoparticles as delivery systems holds great promise for advancing therapeutic approaches for the treatment of cancer. Dr Xianzhou Huang was the team leader.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.